MD Medical Group Develops Russian Medical Educations Based on MGIMO-Med — Group of companies "Mother and child"
en
01.03.2024

MD Medical Group (“MD Medical Group”, “the Group” or “the Company”), one of the largest private healthcare companies in Russia, is expanding its medical competencies and geographical footprint while also developing its educational activities jointly with the Moscow State Institute of International Relations (MGIMO), the country's leading higher education institution, on the basis of MGIMO-Med University established in 2021.

2024 is the third year when MGIMO-Med is accepting applications from potential students. In its inaugural year of 2022, the University offered training only in General Medicine, while now students can join residency programmes in Obstetrics and Gynaecology, Oncology, Therapy, and Surgery.

Going forward, the project will offer new areas of residency and cover other levels of training, including additional professional education. The extensive first-hand experience and research results of MD Medical Group will underpin the training programmes for physicians to-be. The company expects the majority of the University graduates will choose the Group’s healthcare facilities for their further work.

About MGIMO-Med University:

The University Rector is Mark Kurtser holding a Post-Doctoral degree in medicine, member of the Russian Academy of Sciences, founder and CEO of MD Medical Group. ​​​​

MGIMO-Med students receive hands-on training at the Company's Lapino and MD Group Michurinsky multifunctional clinical hospitals boasting all modern medical capabilities, as well as at the MGIMO campus in Odintsovo. Students have their major subjects at the leading medical and research institutions of Moscow and the Moscow Region, including Erisman Federal Research Centre of Hygiene, Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Infectious Diseases Clinical Hospital No. 2, and Forensic Medicine Bureau.

MGIMO-Med University stands out from other medical educational institutions by focusing on training a new generation of medical professionals who are fluent in foreign languages and have expertise in high-demand areas of modern healthcare. That is why MGIMO-Med University prioritizes individual approach to studies, with a limited enrolment of no more than 50 students per course to ensure a top-notch quality of education and knowledge. Another obvious advantage of the University is in-depth studies of English, the international language of medicine. Certain subjects are taught in English as well. MGIMO-Med University's curriculum leveraging best practices of leading global and Russian medical universities and addressing the needs of modern healthcare, along with its focus on foreign language fluency and individualized training, offers its graduates a competitive edge in the healthcare industry.


About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 55 state-of-the-art healthcare facilities, including 11 multidisciplinary hospitals and 44 out-patient clinics in 27 regions of the Russian Federation. In 2022, MD Medical Group's revenue amounted to RUB 27.6 bln. The Company's GDRs are traded on Moscow Exchange (MOEX: MDMG).
Back to news list